NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Adagio Therapeutics Inc. Common Stock (NASDAQ: ADGI)

 
ADGI Technical Analysis
5
As on 25th Jan 2022 ADGI Share Price closed @ 6.74 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 13.78 & Strong Sell for SHORT-TERM with Stoploss of 35.82 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ADGI Share Price

Open 5.84 Change Price %
High 6.97 1 Day 0.56 9.06
Low 5.84 1 Week 1.48 28.14
Close 6.74 1 Month -26.49 -79.72
Volume 2722458 1 Year -14.14 -67.72
52 Week High 56.08 | 52 Week Low 5.26
 
NASDAQ USA Most Active Stocks
XELA 0.55 34.15%
AAPL 159.78 -1.14%
AMD 111.13 -4.63%
SOFI 12.76 -4.06%
NVDA 223.24 -4.48%
MSFT 288.49 -2.66%
SNDL 0.48 4.35%
BBIG 3.01 2.73%
INTC 51.00 -1.81%
PIXY 1.55 -9.88%
 
NASDAQ USA Top Gainers Stocks
CETXW 0.02 100.00%
ZJZZT 37.50 79.86%
AKICW 0.77 60.42%
ZWZZT 22.00 46.67%
SRRA 22.68 46.23%
DBGIW 0.49 40.00%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
APM 2.25 38.89%
 
NASDAQ USA Top Losers Stocks
PTRAW 0.23 -89.59%
DSKEW 0.01 -66.67%
IKNX 19.52 -42.42%
PAVMW 0.03 -40.00%
OTLKW 0.03 -40.00%
XBIOW 1.30 -35.00%
ROVRW 1.30 -34.34%
STMP 0.02 -33.33%
STMP 0.02 -33.33%
IMRNW 0.20 -33.33%
 
 
ADGI
Daily Charts
ADGI
Intraday Charts
Whats New @
Bazaartrend
ADGI
Free Analysis
 
ADGI Important Levels Intraday
RESISTANCE8.92
RESISTANCE8.22
RESISTANCE7.79
RESISTANCE7.36
SUPPORT6.12
SUPPORT5.69
SUPPORT5.26
SUPPORT4.56
 
ADGI Target for Month January
4th UP TARGET76.09
3rd UP TARGET53.85
2nd UP TARGET40.1
1st UP TARGET26.35
1st DOWN TARGET-12.87
2nd DOWN TARGET-26.62
3rd DOWN TARGET-40.37
4th DOWN TARGET-62.61
 
ADGI Weekly Target
4th UP TARGET21.79
3rd UP TARGET16.96
2nd UP TARGET13.98
1st UP TARGET11.00
1st DOWN TARGET2.48
2nd DOWN TARGET-0.50
3rd DOWN TARGET-3.48
4th DOWN TARGET-8.31
 
ADGI Target for Year 2022
4th UP TARGET149.15
3rd UP TARGET103.48
2nd UP TARGET75.25
1st UP TARGET47.02
1st DOWN TARGET-33.54
2nd DOWN TARGET-61.77
3rd DOWN TARGET-90
4th DOWN TARGET-135.67
 
 
ADGI Other Details
Segment EQ
Market Capital 3610127360.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ADGI Address
ADGI
 
ADGI Latest News
 
Your Comments and Response on Adagio Therapeutics Inc. Common Stock
 
ADGI Business Profile
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. Its lead product candidate is the ADG20, a neutralizing antibody that is in Phase II/III clinical trials for the treatment and prevention of coronavirus disease. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. Adagio Therapeutics, Inc. was incorporated in 2020 and is based in Waltham, Massachusetts. Address: 303 Wyman Street, Waltham, MA, United States, 02451
 
2005-2021 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service